Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
WGa01
- Development stage
- Unknown
- Lead developer
- Chengdu Weisijin Biopharmaceutical Technology
- Modality
- Nanoparticles → Drug Delivery Systems, Small Molecules
- Administration
- Intramuscular
01
Overview
WGa01 is a novel nano-adjuvant developed by WestGene Biopharma. It has received Emergency Use Authorization (EUA) in China and is designed to enhance the efficacy of mRNA-based therapeutic cancer vaccines, particularly for Epstein-Barr virus (EBV)-related cancers. The adjuvant is incorporated into mRNA vaccine formulations to boost anti-tumor immunity by activating cytotoxic T-cells, antigen-specific antibodies, and memory T-cells. This immuno-enhancer technology aims to provide robust anti-cancer effects comparable to those achieved with combined CAR-T cell and monoclonal antibody therapies, while also helping prevent tumor recurrence. The delivery system utilizes a proprietary lipid nanoparticle (LNP) platform patented in multiple jurisdictions[3].
- Brand names
- WGa01WGa-01WGa 01
- Other names
- WGa01WGa-01WGa 01
Beyond the preview
Go deeper on WGa01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on WGa01.